感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2020 NTAC/CDC建议：潜伏性结核感染的治疗指南

2020-02-14 美国疾病控制与预防中心 MMWR Recomm Rep. 2020 Feb 14;69(1):1-11.

潜伏性结核感染

2020年2月，美国国家结核病控制协会(NTAC)联合美国疾病控制与预防中心(CDC)共同发布了潜伏性结核感染的治疗指南建议。美国潜伏性结核感染的管理指南最后一次发布是在2000年，在这之后，一些新的治疗方案已经在临床实验中得到评估。本文是对前期指南的更新，提出了段疗程（3-4个月）基于利福霉素的治疗方案在治疗潜伏性结核感染方面优于长疗程异烟肼单药治疗。

中文标题：

2020 NTAC/CDC建议：潜伏性结核感染的治疗指南

英文标题：

Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.

发布机构：

美国疾病控制与预防中心

发布日期：

2020-02-14

简要介绍：

2020年2月，美国国家结核病控制协会(NTAC)联合美国疾病控制与预防中心(CDC)共同发布了潜伏性结核感染的治疗指南建议。美国潜伏性结核感染的管理指南最后一次发布是在2000年，在这之后，一些新的治疗方案已经在临床实验中得到评估。本文是对前期指南的更新，提出了段疗程（3-4个月）基于利福霉素的治疗方案在治疗潜伏性结核感染方面优于长疗程异烟肼单药治疗。

 

拓展指南：与结核相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2020 NTAC/CDC建议：潜伏性结核感染的治疗指南)] GetToolGuiderByIdResponse(projectId=1, id=ec5c31c00186e5b1, title=2020 NTAC/CDC建议：潜伏性结核感染的治疗指南, enTitle=Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020., guiderFrom=MMWR Recomm Rep. 2020 Feb 14;69(1):1-11., authorId=null, author=, summary=2020年2月，美国国家结核病控制协会(NTAC)联合美国疾病控制与预防中心(CDC)共同发布了潜伏性结核感染的治疗指南建议。美国潜伏性结核感染的管理指南最后一次发布是在2000年，在这之后，一些新的治疗方案已经在临床实验中得到评估。本文是对前期指南的更新，提出了段疗程（3-4个月）基于利福霉素的治疗方案在治疗潜伏性结核感染方面优于长疗程异烟肼单药治疗。 , cover=, journalId=null, articlesId=null, associationId=109, associationName=美国疾病控制与预防中心, associationIntro=致力于保护健康和促进预防和控制疾病，设有疾病预防控制中心咨询委员会&mdash;&mdash;联邦咨询委员会，提供卫生监测系统的监测和防止疾病暴发（包括生物恐怖主义），实施疾病预防战略，并保持国家卫生统计与各国和其他合。提供流行病学统计等数据。, copyright=0, guiderPublishedTime=Fri Feb 14 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年2月，美国国家结核病控制协会(NTAC)联合美国疾病控制与预防中心(CDC)共同发布了潜伏性结核感染的治疗指南建议。美国潜伏性结核感染的管理指南最后一次发布是在2000年，在这之后，一些新的治疗方案已经在临床实验中得到评估。本文是对前期指南的更新，提出了段疗程（3-4个月）基于利福霉素的治疗方案在治疗潜伏性结核感染方面优于长疗程异烟肼单药治疗。 </P> <P> </P>拓展指南：<strong>与<font color=red>结核</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=3beda1c001833e77" title="2019 ACIP建议：13价肺炎球菌结核疫苗和23价肺炎球菌多糖疫苗在年龄≥65周岁人群中的应用" target=_blank>2019 ACIP建议：13价肺炎球菌结核疫苗和23价肺炎球菌多糖疫苗在年龄≥65周岁人群中的应用</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=75c8b1c00183135f" title="2019 ATS/CDC/ERS/IDSA临床实践指南：耐药结核病的治疗" target=_blank>2019 ATS/CDC/ERS/IDSA临床实践指南：耐药结核病的治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=e4c8a1c0018151f4" title="抗肺结核药物临床试验技术指导原则（网上征求意见稿）" target=_blank>抗肺结核药物临床试验技术指导原则（网上征求意见稿）</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c8ca91c00180e82e" title="耐药结核病化学治疗指南（2019年简版）" target=_blank>耐药结核病化学治疗指南（2019年简版）</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=02dda1c0018012b1" title="活动性肺结核患者居家治疗感染控制的意见和建议" target=_blank>活动性肺结核患者居家治疗感染控制的意见和建议</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E7%BB%93%E6%A0%B8" target=_blank>有关结核更多指南</a></ul>, tagList=[TagDto(tagId=37943, tagName=潜伏性结核感染)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5855, appHits=256, showAppHits=25, pcHits=2619, showPcHits=4992, likes=21, shares=9, comments=4, approvalStatus=1, publishedTime=Mon Feb 24 23:23:26 CST 2020, publishedTimeString=2020-02-14, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Feb 24 23:23:26 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:03:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 NTAC/CDC建议：潜伏性结核感染的治疗指南)])
2020 NTAC/CDC建议：潜伏性结核感染的治疗指南
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=996642, encodeId=f90199664227, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8185542328, createdName=路人甲zg, createdTime=Tue Jul 06 00:16:32 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996619, encodeId=53e1996619b1, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85542309, createdName=ms2000000603663418, createdTime=Mon Jul 05 23:27:01 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996618, encodeId=391399661881, content=122, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85542309, createdName=ms2000000603663418, createdTime=Mon Jul 05 23:26:41 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896037, encodeId=1a1e89603e9b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/bb9a547d27a44f2f9c543d145ccfd88d/22e12a2d0b08491aa9cb914ea0991d8a.jpg, createdBy=b2902397354, createdName=12348014m27暂无昵称, createdTime=Sun Nov 01 12:51:13 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380748, encodeId=d124380e4880, content=怎么有些指南下载不了，请指点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6f61542970, createdName=guzling, createdTime=Fri Mar 20 12:37:52 CST 2020, time=2020-03-20, status=1, ipAttribution=)]
    2021-07-06 路人甲zg

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=996642, encodeId=f90199664227, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8185542328, createdName=路人甲zg, createdTime=Tue Jul 06 00:16:32 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996619, encodeId=53e1996619b1, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85542309, createdName=ms2000000603663418, createdTime=Mon Jul 05 23:27:01 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996618, encodeId=391399661881, content=122, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85542309, createdName=ms2000000603663418, createdTime=Mon Jul 05 23:26:41 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896037, encodeId=1a1e89603e9b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/bb9a547d27a44f2f9c543d145ccfd88d/22e12a2d0b08491aa9cb914ea0991d8a.jpg, createdBy=b2902397354, createdName=12348014m27暂无昵称, createdTime=Sun Nov 01 12:51:13 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380748, encodeId=d124380e4880, content=怎么有些指南下载不了，请指点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6f61542970, createdName=guzling, createdTime=Fri Mar 20 12:37:52 CST 2020, time=2020-03-20, status=1, ipAttribution=)]
    2021-07-05 ms2000000603663418

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=996642, encodeId=f90199664227, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8185542328, createdName=路人甲zg, createdTime=Tue Jul 06 00:16:32 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996619, encodeId=53e1996619b1, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85542309, createdName=ms2000000603663418, createdTime=Mon Jul 05 23:27:01 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996618, encodeId=391399661881, content=122, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85542309, createdName=ms2000000603663418, createdTime=Mon Jul 05 23:26:41 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896037, encodeId=1a1e89603e9b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/bb9a547d27a44f2f9c543d145ccfd88d/22e12a2d0b08491aa9cb914ea0991d8a.jpg, createdBy=b2902397354, createdName=12348014m27暂无昵称, createdTime=Sun Nov 01 12:51:13 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380748, encodeId=d124380e4880, content=怎么有些指南下载不了，请指点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6f61542970, createdName=guzling, createdTime=Fri Mar 20 12:37:52 CST 2020, time=2020-03-20, status=1, ipAttribution=)]
    2021-07-05 ms2000000603663418

    122

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=996642, encodeId=f90199664227, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8185542328, createdName=路人甲zg, createdTime=Tue Jul 06 00:16:32 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996619, encodeId=53e1996619b1, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85542309, createdName=ms2000000603663418, createdTime=Mon Jul 05 23:27:01 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996618, encodeId=391399661881, content=122, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85542309, createdName=ms2000000603663418, createdTime=Mon Jul 05 23:26:41 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896037, encodeId=1a1e89603e9b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/bb9a547d27a44f2f9c543d145ccfd88d/22e12a2d0b08491aa9cb914ea0991d8a.jpg, createdBy=b2902397354, createdName=12348014m27暂无昵称, createdTime=Sun Nov 01 12:51:13 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380748, encodeId=d124380e4880, content=怎么有些指南下载不了，请指点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6f61542970, createdName=guzling, createdTime=Fri Mar 20 12:37:52 CST 2020, time=2020-03-20, status=1, ipAttribution=)]
    2020-11-01 12348014m27暂无昵称

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=996642, encodeId=f90199664227, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8185542328, createdName=路人甲zg, createdTime=Tue Jul 06 00:16:32 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996619, encodeId=53e1996619b1, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85542309, createdName=ms2000000603663418, createdTime=Mon Jul 05 23:27:01 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996618, encodeId=391399661881, content=122, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd85542309, createdName=ms2000000603663418, createdTime=Mon Jul 05 23:26:41 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896037, encodeId=1a1e89603e9b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/bb9a547d27a44f2f9c543d145ccfd88d/22e12a2d0b08491aa9cb914ea0991d8a.jpg, createdBy=b2902397354, createdName=12348014m27暂无昵称, createdTime=Sun Nov 01 12:51:13 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=380748, encodeId=d124380e4880, content=怎么有些指南下载不了，请指点, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6f61542970, createdName=guzling, createdTime=Fri Mar 20 12:37:52 CST 2020, time=2020-03-20, status=1, ipAttribution=)]
    2020-03-20 guzling

    怎么有些指南下载不了，请指点

    0

相关指南

2015 WHO潜伏结核感染管理指南（中文翻译版）

世界卫生组织(WHO,The World Health Organization) · 2015-07-12

浅读世界卫生组织《潜伏结核感染管理指南》

世界卫生组织(WHO,The World Health Organization) · 2015-10-15

2016 USPSTF建议声明：成人潜伏性结核感染的筛查

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2016-09-06